EyePoint Pharmaceuticals, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.92 | $-1.09 | -18.5% | Miss |
| Q12026 FY2026 | $-0.79 | $-0.99 | -25.3% | Miss |
| Q42025 FY2025 | $-0.78 | $-0.81 | -3.9% | Miss |
Back to EYPT overview · EYPT holders · EYPT KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.